Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hamelmann

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Klinische Padiatrie|May 19, 2015
[Vascular anomaly in the midcheek region of an infant--review of the diagnostic procedure]L Rossler, V Sander, I Teuber, et al.
Klinische Padiatrie|July 17, 2015
[Correction: Vascular Anomaly in the Midcheek Region of an Infant - Review of the Diagnostic Procedure]L Rossler, V Sander, I Teuber, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|November 10, 2015
Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks--Short and Long-term OutcomesN Teig, A Weitkämper, J Rothermel, et al.
American Journal of Respiratory Cell and Molecular Biology|September 30, 1999
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytesE Hamelmann, K Takeda, J Schwarze, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsivenessE Hamelmann, G Cieslewicz, J Schwarze, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 10, 2004
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in miceD Quarcoo, S Weixler, R A Joachim, et al.
Allergy|July 28, 2009
Longitudinal trends of total and allergen-specific IgE throughout childhoodP M Matricardi, A Bockelbrink, C Grüber, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient miceE Hamelmann, A T Vella, A Oshiba, et al.
Chest|October 29, 1998
Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosisG Cieslewicz, G Juszczyk, J Foremny, et al.
The Journal of Allergy and Clinical Immunology|July 29, 1998
Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized miceJ Schwarze, E Hamelmann, G Cieslewicz, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Klinische Padiatrie|May 19, 2015
[Vascular anomaly in the midcheek region of an infant--review of the diagnostic procedure]L Rossler, V Sander, I Teuber, et al.
Klinische Padiatrie|July 17, 2015
[Correction: Vascular Anomaly in the Midcheek Region of an Infant - Review of the Diagnostic Procedure]L Rossler, V Sander, I Teuber, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|November 10, 2015
Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks--Short and Long-term OutcomesN Teig, A Weitkämper, J Rothermel, et al.
American Journal of Respiratory Cell and Molecular Biology|September 30, 1999
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytesE Hamelmann, K Takeda, J Schwarze, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsivenessE Hamelmann, G Cieslewicz, J Schwarze, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 10, 2004
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in miceD Quarcoo, S Weixler, R A Joachim, et al.
Allergy|July 28, 2009
Longitudinal trends of total and allergen-specific IgE throughout childhoodP M Matricardi, A Bockelbrink, C Grüber, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient miceE Hamelmann, A T Vella, A Oshiba, et al.
Chest|October 29, 1998
Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosisG Cieslewicz, G Juszczyk, J Foremny, et al.
The Journal of Allergy and Clinical Immunology|July 29, 1998
Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized miceJ Schwarze, E Hamelmann, G Cieslewicz, et al.
Pageof 10